Genvax Technologies
PrivateLast Round
Grant
Apr 23, 2025
Total Funding Raised
$12.22M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Genvax Technologies is a biotechnology company that develops self-amplifying mRNA (saRNA) and nanoparticle-based vaccines for the animal health industry.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Genvax Technologies Comparables
Compare Genvax Technologies with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Medgene Labs | 80% | |
| Merck & Co., Inc. | 76% | |
| Plumbline Life Sciences, Inc. | 72% |
Genvax Technologies Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Apr 23, 2025 | ||||
| Seed | Feb 3, 2025 | ||||
| Early Funding | Jun 24, 2024 | ||||
| Seed | Aug 9, 2022 | ||||
| Grant | Apr 18, 2022 | ||||
Pre Seed | Feb 1, 2021 |
Genvax Technologies Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Iowa Corn Growers Association | Seed |
| Ag Startup Engine | Seed |
| Summit Agricultural Group | Seed |
| Johnsonville Ventures | Seed |
| Plum Island Animal Disease Center | Grant |
| Next Level Ventures | Seed |
| Foundation for Food & Agriculture Research | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors increased 256% MoM.
- Jun 17, 2026
Monthly visitors increased 30% MoM.
Genvax Technologies Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Genvax Technologies's valuation, stock price, and market status.
Is Genvax Technologies a public or private company?
Genvax Technologies is a private company.
What is the current stock price of Genvax Technologies?
Genvax Technologies is a private company, so its shares have no public market price. Caplight tracks Genvax Technologies's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Genvax Technologies worth (valuation)?
Valuation information for Genvax Technologies is not publicly available.
Can I buy Genvax Technologies stock?
Genvax Technologies shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Genvax Technologies's last funding round?
Genvax Technologies's most recent funding round was Grant on April 23, 2025.
Who are the main investors in Genvax Technologies?
Key investors in Genvax Technologies include Iowa Corn Growers Association, Ag Startup Engine, Summit Agricultural Group, Johnsonville Ventures, Plum Island Animal Disease Center.
Will Genvax Technologies IPO soon?
No public IPO plans have been announced for Genvax Technologies.
How can I track Genvax Technologies secondary market activity?
Caplight tracks bids, offers, and trades in Genvax Technologies's shares on secondary markets.